Accelrys' Q3 Revenues Inch up 1 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Accelrys reported after the close of the market Wednesday that its third quarter revenues increased 1 percent year over year due primarily to a boost from its professional services.

The San Diego-based science informatics firm reported total revenues of $40.9 million for the three months ended Sept. 30, compared to $40.5 million for the third quarter of 2012. On a non-GAAP basis, which includes a deferred revenue fair value adjustment, its revenue for the quarter was $44.3 million, beating the average Wall Street estimate of $43.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.